CN104856799A - Ophthalmic therapy device - Google Patents
Ophthalmic therapy device Download PDFInfo
- Publication number
- CN104856799A CN104856799A CN201510330977.4A CN201510330977A CN104856799A CN 104856799 A CN104856799 A CN 104856799A CN 201510330977 A CN201510330977 A CN 201510330977A CN 104856799 A CN104856799 A CN 104856799A
- Authority
- CN
- China
- Prior art keywords
- pad
- shell
- eyelet
- housing
- treatments device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002560 therapeutic procedure Methods 0.000 title abstract description 12
- 239000000779 smoke Substances 0.000 claims abstract description 49
- 238000011282 treatment Methods 0.000 claims description 35
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- 229920000642 polymer Polymers 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 9
- 230000008569 process Effects 0.000 claims description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 6
- 239000000725 suspension Substances 0.000 claims description 6
- 239000000463 material Substances 0.000 claims description 5
- 238000009413 insulation Methods 0.000 claims description 4
- 229920002379 silicone rubber Polymers 0.000 claims description 3
- 239000004945 silicone rubber Substances 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 13
- 230000004379 myopia Effects 0.000 abstract description 11
- 208000001491 myopia Diseases 0.000 abstract description 11
- 201000009487 Amblyopia Diseases 0.000 abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 6
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000002177 Cataract Diseases 0.000 abstract description 3
- 206010020675 Hypermetropia Diseases 0.000 abstract description 3
- 230000004305 hyperopia Effects 0.000 abstract description 3
- 201000006318 hyperopia Diseases 0.000 abstract description 3
- 238000007599 discharging Methods 0.000 abstract 5
- 208000004350 Strabismus Diseases 0.000 abstract 1
- 210000001508 eye Anatomy 0.000 description 21
- 230000001225 therapeutic effect Effects 0.000 description 16
- 238000001467 acupuncture Methods 0.000 description 10
- 208000030533 eye disease Diseases 0.000 description 10
- 239000003054 catalyst Substances 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 239000010410 layer Substances 0.000 description 7
- 230000001886 ciliary effect Effects 0.000 description 6
- 210000003205 muscle Anatomy 0.000 description 6
- 239000007788 liquid Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 238000009826 distribution Methods 0.000 description 4
- 230000004438 eyesight Effects 0.000 description 4
- 239000004744 fabric Substances 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 238000006385 ozonation reaction Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920000049 Carbon (fiber) Polymers 0.000 description 3
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 3
- 239000004917 carbon fiber Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 239000003999 initiator Substances 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 3
- 239000000693 micelle Substances 0.000 description 3
- 210000004279 orbit Anatomy 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 2
- 241000758789 Juglans Species 0.000 description 2
- 235000009496 Juglans regia Nutrition 0.000 description 2
- 241000208125 Nicotiana Species 0.000 description 2
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 2
- 229910018879 Pt—Pd Inorganic materials 0.000 description 2
- 230000002902 bimodal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 239000000428 dust Substances 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 239000011229 interlayer Substances 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 235000020234 walnut Nutrition 0.000 description 2
- 206010001912 Amblyopia strabismic Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010009866 Cold sweat Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 239000004594 Masterbatch (MB) Substances 0.000 description 1
- 208000008238 Muscle Spasticity Diseases 0.000 description 1
- 208000022873 Ocular disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 201000009406 ametropic amblyopia Diseases 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000004329 axial myopia Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 210000003161 choroid Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- SZGZILRQIYNODJ-UHFFFAOYSA-L disodium;7,12-dihydroquinoxalino[3,2-b]phenazine-2,9-disulfonate Chemical compound [Na+].[Na+].[O-]S(=O)(=O)C1=CC=C2N=C(C=C3C(NC4=CC=C(C=C4N3)S(=O)(=O)[O-])=C3)C3=NC2=C1 SZGZILRQIYNODJ-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000003670 easy-to-clean Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 239000003517 fume Substances 0.000 description 1
- 238000003958 fumigation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004402 high myopia Effects 0.000 description 1
- 210000003701 histiocyte Anatomy 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 230000004344 low myopia Effects 0.000 description 1
- 230000004315 low visual acuity Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000002808 molecular sieve Substances 0.000 description 1
- 230000004423 myopia development Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 239000013618 particulate matter Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 230000002207 retinal effect Effects 0.000 description 1
- 230000001020 rhythmical effect Effects 0.000 description 1
- 210000003786 sclera Anatomy 0.000 description 1
- 201000008525 senile cataract Diseases 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 208000018198 spasticity Diseases 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 201000009485 suppression amblyopia Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000005496 tempering Methods 0.000 description 1
- 229940070527 tourmaline Drugs 0.000 description 1
- 229910052613 tourmaline Inorganic materials 0.000 description 1
- 239000011032 tourmaline Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 208000029257 vision disease Diseases 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Finger-Pressure Massage (AREA)
Abstract
The invention discloses an ophthalmic therapy device. The ophthalmic therapy device comprises a periscope shell, wherein a plurality of convection holes are formed in the shell; an eyelet cushion is arranged on the open end at the reverse side of the shell, and porous lenses communicated with the inner part of the shell are arranged on left and right parts of the eyelet cushion; a nose bridge cushion is arranged between left and right porous lenses, left and right smoke discharging columns are arranged at the upper end of the shell, smoke discharging holes are formed in the tops of the left and right smoke discharging columns, smoke discharging caps are sleeved on the left and right smoke discharging columns, left and right ash outlets are formed at the lower end of the shell, ash receiving slots are formed in the shell, and moxibustion cone fixing tables for placing moxibustion cones are erected in the left and right ash receiving slots. The ophthalmic therapy device has a certain effect to relief and treat ophthalmic diseases such as amblyopia, shortsightedness, hyperopia and strabismus in young children and senior cataracts.
Description
Technical field
The invention belongs to the medical device of a kind for the treatment of or alleviation ocular disease, particularly a kind of ophtalmic treatments device ophthalmic diseasess such as amblyopia, myopia, cataract to certain treatment or mitigation.
background technology
Along with the increase of myopia, amblyopia crowd, various eye treatment, health product also get more and more.Myopia is mainly due to excess eye-using, and ciliary muscle is in spasticity for a long time and causes, and some therapeutic instruments, by tempering ciliary muscle, can make the regulatory function of ciliary muscle strengthen, and has certain help to improving vision.General therapeutic instrument for shortsightedness is all by simulation human eye by nearly vision process extremely far away, and the exercise repeatedly make the rhythmic contraction of ciliary muscle, loosening, recovers ciliary muscle and lenticular regulating power, carry out prevention and therapy myopia.Meanwhile, these therapeutic instruments, also by the massage to around eyes meridian point and nervous tissue, control and regulate visual performance, improving eye blood supply situation, strengthen therapeutic effect further.But above treatment principle fundamentally can not play treatment or mitigation to myopia and amblyopia.
Because an important mechanisms of the generation development of myopia is the contracts last of ciliary muscle, engender tension or spasm, and make choroid be subject to tractive, ocular circulation generation obstacle, secondary eye histiocyte malnutrition and atrophy, cause sclera elasticity to weaken further, cause the generation of axial myopia.
So, how a kind of ophtalmic treatments device is provided, improved by the blood circulation of therapeutic instrument to eyeball deep tissue, dredging the meridian, with reach safety, effectively, the object for the treatment of and the pre-low visual acuity such as myopia prevention, amblyopia oculopathy easily, be that eye illness control worker explores, an important topic of research.
CN201019908U discloses a kind of eye diseases therapy, comprise the housing of a spectacle, it is characterized in that: this housing front is blind end, it offers multiple convection holes, the opening of back side of shell is equiped with eyelet pad, a left side for eyelet pad, right part position is respectively equiped with the porous eyeglass communicated with enclosure interior, left, nose pad is provided with between right porous eyeglass, the upper end of housing is provided with the left side being injected into one with housing, right smoke evacuation post, left, end face and the sidewall of right smoke evacuation post offer exhaust smoke hole, left, right smoke evacuation post is all arranged with rotatable smoke evacuation cap, the smoke evacuation end face of cap and sidewall are provided with the exhaust smoke hole opened and closed that to coincide with the exhaust smoke hole in discharge fume capital face and sidewall, housing lower end is provided with a left side, right ash hole, on it, spiral shell is provided with ash groove, left, in right ash groove, all erection has the moxibustion post fixed mount putting moxibustion post.By reference the full content of this utility model is incorporated to herein.
CN1286966A discloses a kind of medical apparatus and instruments for the treatment of oculopathy.The treatment oculopathy that the medical apparatus and instruments that eye disease treating instrument solves Current therapeutic oculopathy exists is single, controls the problem that table does not effect a permanent cure.The appearance medicine box of this therapeutic instrument, agitator, electric pulse generator are all placed in the interlayer that inside and outside plate is formed, and fix with interlayer, inner panel is fixed with several massage columns, in the centre that several massage columns are formed, eyeshield, medicinal liquid diffuser plate, heater are installed successively, connected by wire or mozzle between these parts, therapeutic instrument scientific structure is simple, to various oculopathy treating both the principal and secondary aspects of a disease, evident in efficacy.
CN101375815A discloses a kind of eye therapeutic apparatus, particularly relate to and a kind of regulate the ametropic disease therapeutic equipments of eye such as myopia, hypermetropia, it is the mould suction nozzle being provided with air duct mated by front end and eyeball, the sebific duct be connected with mould suction nozzle, the negative pressure source that is connected with sebific duct form.
CN101822872A discloses a kind of eye near-infrared light therapeutic apparatus, it is characterized in that: comprise power supply, can human body head be fixed on and cover the eyeshield of eye, to be located on eyeshield and by some near-infrared light sources of Power supply, and correspondence controls some switches of each near-infrared light source break-make respectively, the corresponding eye Chinese medicine acupoint of described near-infrared light source irradiation position, the wave band of described near-infrared light source at least comprises one of 670nm and 830nm.
CN104224435A discloses a kind of therapeutic instrument being used for the treatment of ophthalmic diseases, it is characterized in that: in order to produce, it comprises can excite that patient produces visual effect depending on excitement, visual information transmission, the electric impulse production device that can be converted into the photostimulation to human eye, battery lead plate and drug application are pasted, described electric impulse production device is by wire connection electrode plate, the electric pulse that electric impulse production device produces is transmitted to drug application by battery lead plate and sticks, and the medicinal liquid containing the ingredient can treating ophthalmology visual disorder disease is sticked in described drug application; The electric pulse that described electric impulse production device produces is the multiple harmonic generated after the carrying out of two different pulse frequencies is modulated, in described two pulses, one is low-frequency pulse, frequency range is 30 ~ 60Hz, another is medium-frequency pulse, frequency range is 5000 ~ 7000Hz, and two impulse modulations generate the multiple harmonic of 30 ~ 7000Hz later.
CN203598214U discloses a kind of eye diseases therapy, comprise the housing of single injection-molded, the cuboid of described housing to be cross section be glasses type, it is characterized in that: described housing forward end is blind end and is provided with convection holes, the picture frame agreed with hull shape is installed in described housing, described picture frame is provided with two panels porous eyeglass, the upper end of housing is provided with movable smoke extractor, dust collect plant is provided with below housing, described movable smoke extractor inside is provided with electro-heat equipment, described movable smoke extractor and dust collect plant are two, described housing internal layer is provided with heat-insulation layer.
CN1711980A discloses a kind of vision frequency spectrograph, comprise light source body, body and eyepatch body, light source body is arranged in this eyepatch body, and this eyepatch body is arranged on this body, it is characterized in that: also comprise tumbler, this eyepatch body is rotatably arranged on body by this tumbler.
CN204016856U discloses a kind of eye socket acupuncture and moxibustion therapeutic apparatus, it comprises acupuncture and moxibustion therapy instrument apparatus, and wire is characterized in that: the eye patch of eyeshield shape has eyelet, be provided with acupuncture pole piece around eyelet periphery, acupuncture pole piece is by wire and acupuncture and moxibustion therapy instrument apparatus UNICOM.
CN1203067A discloses a kind of multifunctional therapeutic apparatus for ophthalmopathy, it is by adjustable oscillation inverter circuit, fixed frequency oscillating circuit, the electronic switching circuit of power circuit, frequency of oscillation and dutycycle, the liquid crystal glasses eyeglass before right and left eyes and Plastic eyeglasses mirror holder composition.
CN203662971U discloses a kind of eye diseases therapy, it is characterized in that: before two eye positions of described eyeshield body, be provided with carbon fiber wire heater, be provided with nonwoven, through air layer of cloth below, described nonwoven, through air layer of cloth is provided with multiple tourmaline particle bag near each acupuncture point around two eye sockets, between carbon fiber wire heater and nonwoven, through air layer of cloth, be provided with medicine cloth bag, described carbon fiber wire heater connects the controller with temperature control equipment.
CN202961117U discloses a kind of eye fumigation massage therapeutic equipment, comprising: steam gassing machine; By the medical ultrasonic atomizer that the first steam guiding tube is connected with steam gassing machine; And the eye masseur to be connected with medical ultrasonic atomizer by the second steam guiding tube.
" introduce a kind of moxibustion spectacle frame ", Chen Shaohua etc., Chinese TCM Ophthalmology magazine, 12nd volume the 1st phase, in February, 2002, disclose in spectacle-frame with at the bottom of appropriate absorbent cotton pad, put into walnut shell, the herb liquid of the another preparation of instillation is a little, is inserted in respectively on medicine plug-in unit by moxa roll, reserves gap between moxa roll and walnut shell, light moxa roll, put on one's glasses, can carry out moxibustion to acupuncture point around eye socket, during treatment, patient opens eyes.
Eye diseases therapy disclosed in the CN201019908U granted patent of previous application has been proved to be a kind for the treatment of or has alleviated the comparatively effective device of the symptom such as amblyopia, hypermetropia, be widely used, but the present inventor finds, in the apparatus, the conventional nose pad used and eyelet cushion material easily become sticky under the effect of acupuncture smog, even cause using and scrapping, the present invention is based on this and surprisingly find, and through large quantity research and test, obtain the present invention.
Summary of the invention
The object of the invention is to solve the problem, the present inventor is through further investigation and great many of experiments, and propose a kind of ophtalmic treatments device, nose pad and the eyelet pad of this ophtalmic treatments device are made up of release polymer.
In one aspect of the invention, provide a kind of ophtalmic treatments device, it comprises the housing of periscopic, this housing front is blind end, it offers multiple convection holes, the opening of back side of shell is equiped with eyelet pad, a left side for eyelet pad, right part position is respectively equiped with the porous eyeglass communicated with enclosure interior, left, nose pad is provided with between right porous eyeglass, the upper end of housing is provided with the left side being injected into one with housing, right smoke evacuation post, left, the end face of right smoke evacuation post is provided with exhaust smoke hole, left, right smoke evacuation post is all arranged with smoke evacuation cap, the end face of smoke evacuation cap is provided with adjustable exhaust smoke hole, exhaust smoke hole is provided with and can closes blade and knob post, the lower end of housing is provided with a left side, right ash hole, which is provided with ash groove, left, in right ash groove, all erection has the moxibustion post fixed station putting moxibustion post, it is characterized in that: described eyelet pad and nose pad are made up of release polymer.
The present inventor furthers investigate the composition of moxibustion tobacco and causes the reason be clamminess, and proposes described eyelet pad and nose pad is made up of release polymer.Preferably, described polrvinyl chloride is the polrvinyl chloride produced by microdroplet suspension process.
Described microdroplet suspension process comprises the following steps: (1) by vinyl chloride, water, emulsifying agent and oil-soluble initiator under the effect of dispersion pump, the Vinyl Chloride Monomer emulsion dispersion making it be formed to maintain by mechanical shearing; (2) be polymerized by this emulsion dispersion, polymerization temperature is 50-80 DEG C, and the Vinyl Chloride Monomer emulsion droplet of described emulsifying forms the latex that mean diameter is 5.5-10.5 μm after polymerization; (3) described latex is removed moisture through spraying dry, then carry out the granule of drying collecting rear wind by bag hose and deliver to pulverizer and carry out micronizing, the mean particle size after pulverizing is 3-5 μm, is preferably 4 μm; More preferably, particle size distribution is bimodal distribution, finds unexpectedly, and when particle size distribution is bimodal distribution, the surface viscosity of molded thing is minimum and in use the most stable.Latex after above-mentioned pulverizing is as being shaped to eyelet pad and nose pad masterbatch used.Molding can adopt injection mo(u)lding or molded.
Described oil-soluble initiator can oil-soluble initiator known by skilled person.
Of the present invention one preferred in, described emulsifying agent is amphipathic emulsifying agent.More preferably, the structural formula of described amphipathic emulsifying agent is as follows:
。
The preparation of this emulsifying agent can be carried out with reference to the synthetic method of general sulfonate emulsifier.
Research finds, can the stability of dispersion liquid determine microdroplet suspension polymerisation and carry out smoothly, and the size of dispersant liquid drop and the carrying out be polymerized and the performance of polymer obtained have substantial connection, and the size of drop and emulsifying agent are due to substantial connection.When emulsifying agent hydrophilic is larger, micelle can not be formed in water, when emulsifying agent hydrophilic is less, due to the effect of lipophilic group, can not micelle be formed.Based on this, the present inventor develops mentioned emulsifier first, this emulsifying agent has best HLB value, makes it possible to guarantee to be formed in water stablize micelle and the right height of polymer poly obtained and even, and can obtain the desirable latex that mean diameter is 5.5-10.5 μm.
High and the viscosity stabilization by the release polymer degree of polymerization that the method is obtained.
In the most preferred embodiment of the present invention, the surface of described eyelet pad and nose pad is via ozonization mistake.
Ozonization can adopt the ozone of higher concentration eyelet pad and the firm molding of nose pad complete time carry out, can avoid like this padding surperficial overdrying, thus avoid pad surface checking.The present inventor finds after deliberation, the ozonization of eyelet pad and nose pad, and ozone is only had an effect at film surface, does not have significant ozone to penetrate into pad inner, and the outer surface of glove after ozonization becomes sliding by gluing, and inviscid, its tensile property is constant.Infer that its mechanism is as follows: form ester group by following reaction, due to the formation of ester group, the polarity of polymer surfaces is increased, thus the polymer with favorable lubricating property can be bonded with eyelet pad and nose pad surface forming particulate matter preferably.Its reaction mechanism is as follows:
Wherein X is chlorine.
In a preferred embodiment, described release polymer is when being shaped to eyelet pad and nose pad, and blending has starch based on release polymer weighing scale 1-5 % by weight or Pulvis Talci.
Described housing internal layer can be provided with heat insulation inner bag.
Described moxibustion post fixed station can be provided with fixed leg, pallet, pallet guard bar.
Described eyelet pad can be silicone rubber or sponge material.
The eyelet pad surrounding of described back side of shell may correspond to and is respectively provided with Magnetotherapeutic apparatus in human body yang white cave and SIBAI point place.
The left and right end of described back side of shell can be provided with adjustable fixing band.
Described housing bottom is provided with an adjustable fixed support of activity.
Inventive shell have employed integral structure, overcomes the defect that split type instrument height warm deformation exists.Smoke evacuation post overcoat has the smoke evacuation cap of, on smoke evacuation cap adjustable size exhaust smoke hole, the exhaust smoke hole of smoke evacuation post can be regulated by rotating smoke evacuation cap, thus regulate exhaust smoke level, reach the object of regulation heating body burning velocity and efficacy strength.The coupling part of back side of shell porous eyeglass and eyelet pad silastic material liner, make human body sensory comfortable, the inner corresponding human body yang white cave of housing and SIBAI point place respectively arrange a Magnetotherapeutic apparatus, two ash holes are left in housing lower end, it is bolted with ash groove, moxibustion post fixed station is provided with in ash groove, instead of original locking pin used on inconvenient smoke evacuation cap, because moxibustion post fixed rack structure is simple, so Folium Artemisiae Argyi moxibustion post or carbonization smokeless moxibustion post all applicable, and use and easy to clean, not easily flame-out, ventilation condition is good, easy firing, working stability.
The present invention adopts naturopathy and the bionics principle of the Chinese traditional Chinese medical science.During instrument work, the heat that moxibustion post burning in mirror body produces directly improves ocular circulation through porous eyeglass, and the stimulation by being thirty minutes long to the acupuncture point such as limit Zanzhu, Yuyao, te 23, chengqi, Jingming, Sibai near the eyes, adjust the physiological equilibrium of each anatomical tissue structure nutrition of eye and metabolism, reach the effect that treatment amblyopia and myopia are treated and prevented.
In another aspect of this invention, additionally provide a kind of ophtalmic treatments device external member, this external member comprises aforementioned ophtalmic treatments device and moxibustion post.
In an especially preferred embodiment, doped with the Pt-Pd/ZSM-12 catalyst accounting for moxibustion post gross weight 0.001-0.01 % by weight in described moxibustion post, this catalyst is the loaded catalyst of the molecular sieve carried Pt-Pd of ZSM-12, wherein Pt:Pd=1:5-5:1(mole), the weight of active component Pt and Pd is the 1.0-5.0 % by weight of this loaded catalyst gross weight.This catalyst adopts conventional infusion process preparation.In normal conditions of use, this catalyst can make the CO content in moxibustion tobacco reduce by more than 70%.Described catalyst is preferably entrained in moxibustion post in powder form.
The present invention adopts moxibustion therapy, for around eyes acupuncture point and the effect of eyeball deep tissue, to eyeball without extruding, easy and simple to handle, safe and reliable, without any side effects to human body; Therapeutic effect is good, takes effect first.General low myopia only needs 1 to 2 course for the treatment of (30 days per courses for the treatment of, one day 1 time), and vision can recover normal; High myopia is played and controls development, improve vision simultaneously, prevent the object of retinal complication; Significant curative effect is had to children's myopia using (ametropic amblyopia, anisometropic amblyopia, strabismic amblyopia) and senile cataract (in early days).
Accompanying drawing explanation
Fig. 1 is structural representation of the present invention;
Fig. 2 is internal structure schematic diagram of the present invention;
Fig. 3 is structure schematic diagram of the present invention;
Fig. 4 is ash groove of the present invention and moxibustion post fixed rack structure schematic diagram.
Detailed description of the invention
Below in conjunction with drawings and Examples, the present invention is further illustrated:
embodiment 1
See accompanying drawing 1, 2, 3, 4, ophtalmic treatments device, comprise the housing 10 of a spectacle, wherein, this housing 10 front is blind end, it offers multiple convection holes 11, as shown in Figure 3, the opening at housing 10 back side is equiped with eyelet pad 21, a left side for eyelet pad 21, right part position is respectively equiped with the porous eyeglass 19 communicated with housing 10 inside, left, nose pad 20 is provided with between right porous eyeglass 19, the upper end of housing 10 is provided with the left side being injected into one with housing 10, right smoke evacuation post 12, left, the end face of right smoke evacuation post 12 offers exhaust smoke hole 13, left, right smoke evacuation post 12 is all arranged with smoke evacuation cap 14, the end face of smoke evacuation cap 14 is provided with adjustable exhaust smoke hole 15, exhaust smoke hole 15 is provided with and can closes blade and knob post 13, housing 10 lower end is provided with a left side, right ash hole 16, on it, spiral shell is provided with ash groove 17, left, in right ash groove 17, all erection has the moxibustion post fixed station 30 putting moxibustion post 40, this housing 10 internal layer is provided with heat insulation inner bag 18, this moxibustion post fixed station 30 is provided with fixed leg, pallet 32, pallet guard bar 31, this eyelet pad 21 is silicone rubber or sponge material, eyelet pad 21 surrounding at this housing 10 back side corresponds to human body yang white cave and SIBAI point place is respectively provided with Magnetotherapeutic apparatus 22,23, the left and right end at this housing 10 back side is provided with adjustable fixing band 24, an adjustable fixed support of activity is provided with bottom this housing 10.The polrvinyl chloride that described eyelet pad and nose pad adopt microdroplet suspension process to produce is molded.
comparative example 1
With the difference of embodiment 1, comparative example 1 is only that eyelet pad and nose pad adopt commercially available polrvinyl chloride (obtaining from Qilu Petrochemical Company), this vinyl chloride is produced by solution polymer method.
Eyelet pad and the nose pad of ophtalmic treatments device embodiment 1 and comparative example 1 obtained carry out tackiness test.In normal conditions of use, by user, the eyelet pad of embodiment 1 and nose pad feel that obvious tack-time is 18 months, and in comparative example 1 by user, eyelet pad and nose pad feel that obvious tack-time is 6 months.As can be seen from the above results obviously, according to eyelet pad of the present invention and nose pad, there is the obviously longer life-span, thus make the life of whole device, greatly reduce cost.
The open the present invention of this written description use-case, comprises optimal mode, and also enables those skilled in the art manufacture and use the present invention.Of the present inventionly the scope of granted patent can be defined by the claims, and other example that those skilled in the art expect can be comprised.If other example this has the structural element of the literal language not differing from claims, if or other example this comprises and the equivalent structure element of the literal language of claims without substantial differences, then other example this is intended to be within the scope of claims.Can not cause under inconsistent degree, be incorporated herein by reference to by all references part of reference herein.
Claims (10)
1. an ophtalmic treatments device, comprise the housing of periscopic, this housing front is blind end, it offers multiple convection holes, the opening of back side of shell is equiped with eyelet pad, a left side for eyelet pad, right part position is respectively equiped with the porous eyeglass communicated with enclosure interior, left, nose pad is provided with between right porous eyeglass, the upper end of housing is provided with the left side being injected into one with housing, right smoke evacuation post, left, the end face of right smoke evacuation post is provided with exhaust smoke hole, left, right smoke evacuation post is all arranged with smoke evacuation cap, the end face of smoke evacuation cap is provided with adjustable exhaust smoke hole, exhaust smoke hole is provided with and can closes blade and knob post, the lower end of housing is provided with a left side, right ash hole, which is provided with ash groove, left, in right ash groove, all erection has the moxibustion post fixed station putting moxibustion post, it is characterized in that: described eyelet pad and nose pad are made up of release polymer.
2. ophtalmic treatments device according to claim 1, is characterized in that: described polrvinyl chloride is the polrvinyl chloride produced by microdroplet suspension process.
3. ophtalmic treatments device according to claim 1 and 2, is characterized in that: in described microdroplet suspension process, and the emulsifying agent of use is amphipathic emulsifying agent.
4. ophtalmic treatments device according to claim 1 and 2, is characterized in that: described housing internal layer is provided with heat insulation inner bag.
5. ophtalmic treatments device according to claim 1 and 2, is characterized in that: described moxibustion post fixed station is provided with fixed leg, pallet, pallet guard bar.
6. ophtalmic treatments device according to claim 1 and 2, is characterized in that: described eyelet pad is silicone rubber or sponge material.
7. ophtalmic treatments device according to claim 1 and 2, is characterized in that: the eyelet pad surrounding of described back side of shell corresponds to human body yang white cave and SIBAI point place is respectively provided with Magnetotherapeutic apparatus.
8. ophtalmic treatments device according to claim 5, is characterized in that: the left and right end of described back side of shell is provided with adjustable fixing band.
9. an ophtalmic treatments device external member, this external member can comprise according to ophtalmic treatments device in any one of the preceding claims wherein and moxibustion post.
10. optionally can be used for eyelet pad and the nose pad of ophtalmic treatments device according to any one of claim 1-8, described eyelet pad and nose pad are made up of release polymer.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330977.4A CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510330977.4A CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104856799A true CN104856799A (en) | 2015-08-26 |
| CN104856799B CN104856799B (en) | 2017-04-05 |
Family
ID=53903284
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510330977.4A Active CN104856799B (en) | 2015-06-16 | 2015-06-16 | Ophtalmic treatments device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104856799B (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105498016A (en) * | 2016-01-13 | 2016-04-20 | 孟媛 | Lacrimal passage irrigation water collector |
| CN108042345A (en) * | 2017-12-26 | 2018-05-18 | 武汉浩宏科技有限公司 | Vibration massage therapy instrument is fumigated in a kind of ophthalmology water-bath |
| CN108113877A (en) * | 2017-12-29 | 2018-06-05 | 武汉佰美斯医疗科技有限公司 | A kind of cooling ophthalmology physiotherapy equipment |
| CN108670814A (en) * | 2018-06-01 | 2018-10-19 | 曹利成 | A kind of eye moxibustion massage instrument and its Chinese medicine walnut shell medicament used |
| CN109330843A (en) * | 2018-11-26 | 2019-02-15 | 连云港市明医疗科技有限公司 | It is a kind of to prevent and treat near-sighted device |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006102406A (en) * | 2004-10-01 | 2006-04-20 | Kimio Mizukoshi | Myopia preventing and visual acuity restoring device |
| CN201019908Y (en) * | 2007-03-26 | 2008-02-13 | 汪琰琪 | Ophthalmology treating instrument |
| CN201131847Y (en) * | 2007-12-27 | 2008-10-15 | 申晓丽 | Magneto-moxibustion integration hypometropia and amblyopia therapeutic equipment |
| JP2010063542A (en) * | 2008-09-09 | 2010-03-25 | Masaki Ariga | Instrument for curing visual fatigue |
| CN202154855U (en) * | 2011-01-25 | 2012-03-07 | 黄春源 | Comprehensive traditional Chinese medicine therapeutic apparatus for myopia and amblyopia |
| CN102952224A (en) * | 2011-08-26 | 2013-03-06 | 沈阳化工股份有限公司 | Low-polymerization-degree polyvinyl chloride pasty resin preparation method |
-
2015
- 2015-06-16 CN CN201510330977.4A patent/CN104856799B/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006102406A (en) * | 2004-10-01 | 2006-04-20 | Kimio Mizukoshi | Myopia preventing and visual acuity restoring device |
| CN201019908Y (en) * | 2007-03-26 | 2008-02-13 | 汪琰琪 | Ophthalmology treating instrument |
| CN201131847Y (en) * | 2007-12-27 | 2008-10-15 | 申晓丽 | Magneto-moxibustion integration hypometropia and amblyopia therapeutic equipment |
| JP2010063542A (en) * | 2008-09-09 | 2010-03-25 | Masaki Ariga | Instrument for curing visual fatigue |
| CN202154855U (en) * | 2011-01-25 | 2012-03-07 | 黄春源 | Comprehensive traditional Chinese medicine therapeutic apparatus for myopia and amblyopia |
| CN102952224A (en) * | 2011-08-26 | 2013-03-06 | 沈阳化工股份有限公司 | Low-polymerization-degree polyvinyl chloride pasty resin preparation method |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105498016A (en) * | 2016-01-13 | 2016-04-20 | 孟媛 | Lacrimal passage irrigation water collector |
| CN105498016B (en) * | 2016-01-13 | 2019-01-01 | 青岛市妇女儿童医院 | A kind of lacrimal passage cleaning water collector |
| CN108042345A (en) * | 2017-12-26 | 2018-05-18 | 武汉浩宏科技有限公司 | Vibration massage therapy instrument is fumigated in a kind of ophthalmology water-bath |
| CN108113877A (en) * | 2017-12-29 | 2018-06-05 | 武汉佰美斯医疗科技有限公司 | A kind of cooling ophthalmology physiotherapy equipment |
| CN108670814A (en) * | 2018-06-01 | 2018-10-19 | 曹利成 | A kind of eye moxibustion massage instrument and its Chinese medicine walnut shell medicament used |
| CN109330843A (en) * | 2018-11-26 | 2019-02-15 | 连云港市明医疗科技有限公司 | It is a kind of to prevent and treat near-sighted device |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104856799B (en) | 2017-04-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104856799B (en) | Ophtalmic treatments device | |
| CN205094967U (en) | Multiple mode therapeutic instrument of ophthalmology | |
| CN202909085U (en) | Eye massage instrument | |
| CN107320240A (en) | A kind of adaptive eye physical therapy device | |
| CN102847232A (en) | Eye massager | |
| CN101822872A (en) | Eye near-infrared light therapeutic apparatus | |
| CN104997626A (en) | Novel intelligent moxibustion physiotherapy eye care instrument | |
| CN104382729A (en) | Vision correction training system and method | |
| CN2684798Y (en) | Multifunction myopia and brain health care treating instrument | |
| CN104941062A (en) | Heatable acupuncture instrument for preventing poor vision of teenagers | |
| CN201019908Y (en) | Ophthalmology treating instrument | |
| CN201049016Y (en) | Therapeutic instrument for ophthalmology | |
| CN205459822U (en) | Massage therapy appearance is fumigated to portable dry eyes | |
| CN210811963U (en) | Traditional Chinese medicine fumigation hot compress massage xerophthalmia therapeutic instrument | |
| CN112402250A (en) | Ophthalmologic postoperative care device and using method thereof | |
| CN104958833A (en) | Portable adjustable acupuncture instrument for treating amblyopia | |
| CN112137849A (en) | Bionic vision training instrument capable of achieving double light supplement for back pole of eye ground and peripheral vision of eye ground | |
| CN216021659U (en) | Clinical eye shade of using of ophthalmology | |
| CN213252615U (en) | High-red light structure capable of relieving myopia fatigue and eye physical therapy device | |
| CN206120877U (en) | Add hot type burden ions introduced into atomizing device | |
| CN211024013U (en) | Eye disease fumigation therapeutic instrument | |
| US10512586B1 (en) | System and method for vision rehabilitation therapy | |
| CN203598214U (en) | Ophthalmology therapeutic instrument | |
| CN201073376Y (en) | Novel myopic eye massage and treatment equipment | |
| CN208851969U (en) | A kind of stifling eyeshade |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| EXSB | Decision made by sipo to initiate substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic therapy device Effective date of registration: 20190222 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: 2019320000102 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200416 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: 2019320000102 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic therapy device Effective date of registration: 20200420 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980001626 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210819 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980001626 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic treatment device Effective date of registration: 20210820 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY Co.,Ltd. Registration number: Y2021980008026 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221017 Granted publication date: 20170405 Pledgee: Lianyungang nuclear power station sub branch of Bank of China Ltd. Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: Y2021980008026 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Ophthalmic treatment device Effective date of registration: 20221018 Granted publication date: 20170405 Pledgee: Bank of China Limited Lianyungang Economic and Technological Development Zone Branch Pledgor: LIANYUNGANG YIMING MEDICAL TECHNOLOGY CO.,LTD. Registration number: Y2022980018663 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |